FDA Device Intelligence
HomeANACAPA TECHNOLOGIES, INC. › Anasept Antimicrobial Skin and Wound Cleanser

Anasept Antimicrobial Skin and Wound Cleanser

ANACAPA TECHNOLOGIES, INC. · Model 4004SC · UDI-DI 00367180400441

FQHFRO Prescription
1
510(k) clearances
4,888
Adverse events (5 deaths)
29
Recalls
140
Facilities

Description

Anasept® Antimicrobial Skin and Wound Cleanser is a clear, isotonic liquid that helps in the mechanical removal of the debris from the application site; while delivering 0.057% broad spectrum antimicrobial sodium hypochlorite. Anasept® also inhibits the growth of bacteria such as Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, Proteus mirabilis, Serratia marcescens, Acinetobacter baumannii, Clostridium difficile and antibiotic resistant strains such as Methicillin resistant Staphylococcus aureus (MRSA), Vancomycin resistant Enterococcus faecalis (VRE), Carbapenem resistant E.coli (CRE) that are commonly found in wound bed as well as fungi such as Aspergillus niger, Candida albicans and Candida auris.

Recalls

DateFirmReason
2024-03-19Medtronic Perfusion SystemsPotential for unsealed sterile packing.
2022-05-25Mckesson Medical-Surgical Inc. Corporate OfficeFacility Temperature excursions (from June 2021-August 2021) prior to delivery; exposure to higher temperatures may have impacted product effectiveness. All lots received between 0
2019-08-16IrriMAX CorporationPotential defect in the sterile pouch seal, which may result in a lack of sterility assurance.
2019-01-24Maquet Cardiovascular, LLCPotential lack of carbon dioxide (CO2) flow that may result in a procedural delay during off-pump coronary artery bypass (OPCAB).
2017-11-09Stryker Instruments Div. of Stryker CorporationLack of sterility assurance as bioburden levels were found to be higher than internal acceptable rates.
2017-09-05Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical CompanyLack of sterility assurance: leaking containers which could lead to exposure to infectious agents.
2015-05-08Stryker Instruments Div. of Stryker CorporationPotential sterility breach in the packaging.
2015-02-11EXP Pharmaceutical Services CorpEXP did not register as a medical device establishment, list the devices being recalled, or establish its own quality system and instead relied on the fact that its vendors were re
2010-10-04Stryker Instruments Division of Stryker CorporationThere is potential for a breach in sterility in the blister packaging. This can lead to the use of non-sterile product which, if contaminated, could lead to a patient infection.
2010-10-04Stryker Instruments Division of Stryker CorporationThere is potential for a breach in sterility in the blister packaging. This can lead to the use of non-sterile product which, if contaminated, could lead to a patient infection.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.